This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Gastroenterology
Gastroenterology
New generation compound for chronic constipation
Rapid response in Crohn’s patients
Humira achieves remission in Crohn’s patients, says study
FDA backs irritable bowel treatment
FDA approves bowel function drug
New drug to treat Crohn’s approved
Shares soar after generic drug deal
CHMP rejects UCB’s Cimzia for second time
Certolizumab pegol for the treatment of Crohn’s disease
TNF-alpha-targeted therapy in inflammatory arthritides: a valuable option?
Mesalazine approved for ulcerative colitis
Early data released from Phase IIIb Cimzia trial
« Previous
1
…
13
14
15
16
17
…
20
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: